|
N-((5S,10R)-7,9-dibromo-10-hydroxy-8-methoxy-1-oxa-2-azaspiro(4.5)deca-2,6,8-triene-3-carboxy)-4-aminobutanoic acid
|
C522147 |
|
|
N-(3-fluoro-4-(5-phenylthieno(2,3-d)pyrimidin-4-yloxy)phenyl)-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide
|
C561755 |
|
|
hamigerol A
|
C522148 |
|
|
NTF 1836
|
C561756 |
|
|
hamigerol B
|
C522149 |
|
|
2-morpholin-7-(pyridin-2-ylmethoxy)-4H-naphth(2,1-e)-1,3-oxazin-4-one
|
C561757 |
|
|
2-(4-(nitrooxymethyl)benzamido)phenyl 4-(nitrooxymethyl)benzoate
|
C561758 |
|
|
4-(phenylcarbamoyl)benzyl nitrate
|
C561759 |
|
|
thailandolide A
|
C522150 |
|
|
thailandolide B
|
C522151 |
|
|
Dusp22 protein, mouse
|
C522152 |
|
|
Zfrp8 protein, Drosophila
|
C522153 |
|
|
Grem1 protein, mouse
|
C522154 |
|
|
rga-2 protein, C elegans
|
C522155 |
|
|
Athabaskan severe combined immunodeficiency
|
C536786 |
|
|
Spastic ataxia Charlevoix-Saguenay type
|
C536787 |
|
|
Craniosynostosis radial aplasia syndrome
|
C536788 |
|
|
Craniosynostosis, anal anomalies, and porokeratosis
|
C536789 |
|
|
Trisomy 13 Syndrome
|
D000073839 |
[A chromosome disorder associated with TRISOMY of all or part of CHROMOSOME 13. Clinical manifestations include CONGENITAL HEART DEFECTS (e.g., PATENT DUCTUS ARTERIOSUS), facial malformations (e.g., CLEFT LIP; CLEFT PALATE; COLOBOMA; MICROPHTHALMIA); HYPOTONIA, digit malformations (e.g., POLYDACTYLY or SYNDACTYLY), and SEIZURES and severe INTELLECTUAL DISABILITY associated with NERVOUS SYSTEM MALFORMATIONS.
] |
|
CC-223
|
C000601736 |
|
